Presentation GI2 2012 Rationale and Background to Treat Resistant Hypertension with Renal Denervation Presenter: Martin B. Leon April 13, 2012
Presentation GI2 2012 What is in the Pipeline for Coronary Artery Disease? Presenter: Martin B. Leon April 13, 2012
Presentation GI2 2012 The BioFreedom™ DES: Late Results, Technology Challenges, and Next Steps Presenter: Eberhard Grube April 13, 2012
Presentation GI2 2012 10 Reasons Why the Metallic Drug-eluting Stent Should be Replaced by Bioresorbable Scaffold Presenter: Patrick W. Serruys April 12, 2012
Presentation GI2 2012 New devices for heart failure and pulmonary hypertension Presenter: Saibal Kar April 12, 2012
Presentation GI2 2012 How to Improve TAVR Safety? The Role of Ancillary Devices Presenter: Martin B. Leon April 12, 2012
Presentation GI2 2012 Starting with the Idea: Defining the Unmet Needs Presenter: Martin B. Leon April 12, 2012
Presentation Clinical Outcomes After TAVR Using Valve Academic Research Consortium Definitions Presenter: Philippe Genereux April 12, 2012
Presentation GI2 2012 What Technology Modifications Required for Bioabsorbable Scaffolds to Broaden Indications for USE Presenter: Ron Waksman April 12, 2012